Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 167 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1040. Clear
Clear
Q1
CAMBIA HEALTH SOLUTIONS for CAMBIA HEALTH SOLUTIONS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid
View →
Q1
MERCK & CO, INC. for MERCK & CO INC
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Animals
View →
Q1
MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q1
MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Budget/Appropriations
View →
Q1
MARSHALL & POPP, LLC for PFIZER, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
MARSHALL & POPP, LLC for AMGEN USA INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Trade (domestic/foreign), Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark
View →
Q1
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Budget/Appropriations, Copyright/Patent/Trademark
View →
Q1
RADIUS ADVOCACY, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Copyright/Patent/Trademark, Pharmacy
View →
Q1
BCBSM, INC. for BCBSM INC
1st Quarter (Jan 1 - Mar 31) 2025 · Minnesota · House · Senate
Budget/Appropriations, Health Issues, Pharmacy
View →
Q1
BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. for BLUE CROSS AND BLUE SHIELD OF KANSAS INC
1st Quarter (Jan 1 - Mar 31) 2025 · Kansas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
AARP for AARP
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Agriculture, Law Enforcement/Crime/Criminal Justice
View →
Q1
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View →
Q1
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
INTELLECTUAL PROPERTY OWNERS ASSOCIATION for INTELLECTUAL PROPERTY OWNERS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark
View →
Q1
T1INTERNATIONAL USA for T1INTERNATIONAL USA
1st Quarter (Jan 1 - Mar 31) 2025 · Maine · House · Senate
Health Issues
View →
Q1
THE GIBSON GROUP, LLC for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $30,000.00 income
Health Issues, Labor Issues/Antitrust/Workplace, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Previous Page 7 of 7

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem